RAFAEL HOLDINGS, INC. Earnings Per Share, Basic and Diluted
RAFAEL HOLDINGS, INC. (RFL) reported Earnings Per Share, Basic and Diluted of -$0.12 per share for the 3-month period ending 2022-01-31, per its 10-Q filed 2022-03-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-17
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2022-01-31 was -$0.12.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-10-31 was -$5.91.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-07-31 was -$0.71.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-04-30 was -$0.15.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.49.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.66.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.35.
- RAFAEL HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.93.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-01-31 | -$0.12 10-Q · filed 2022-03-17 | -$5.91 10-Q · filed 2022-03-17 | -$6.78 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$7.11 derived: net income ÷ weighted average shares · filed 2023-03-14 | |
| 2021-10-31 | -$5.91 10-Q/A · filed 2022-02-28 | -$6.49 10-Q · filed 2021-12-15 | -$6.84 derived: net income ÷ weighted average shares · filed 2022-12-13 | -$7.18 derived: net income ÷ weighted average shares · filed 2022-12-13 | -$7.81 derived: net income ÷ weighted average shares · filed 2022-12-13 |
| 2021-07-31 | -$0.71 derived: net income ÷ weighted average shares · filed 2022-10-31 | -$0.88 derived: net income ÷ weighted average shares · filed 2022-10-31 | -$1.38 derived: net income ÷ weighted average shares · filed 2022-10-31 | -$1.49 10-K · filed 2021-10-18 | |
| 2021-04-30 | -$0.15 10-Q · filed 2021-06-14 | -$0.65 derived: net income ÷ weighted average shares · filed 2022-06-14 | -$0.75 10-Q · filed 2021-06-14 | ||
| 2021-01-31 | -$0.50 10-Q · filed 2022-03-17 | -$0.60 10-Q · filed 2022-03-17 | |||
| 2020-10-31 | -$0.09 10-Q/A · filed 2022-02-28 | ||||
| 2020-07-31 | -$0.66 10-K · filed 2021-10-18 | ||||
| 2020-04-30 | -$0.14 10-Q · filed 2021-06-14 | -$0.32 10-Q · filed 2021-06-14 | |||
| 2020-01-31 | -$0.08 10-Q · filed 2021-03-17 | -$0.18 10-Q · filed 2021-03-17 | |||
| 2019-10-31 | -$0.10 10-Q · filed 2020-12-15 | ||||
| 2019-07-31 | -$0.35 10-K · filed 2020-10-29 | ||||
| 2019-04-30 | -$0.07 10-Q · filed 2020-06-09 | -$0.19 10-Q · filed 2020-06-09 | |||
| 2019-01-31 | -$0.08 10-Q · filed 2020-03-05 | -$0.12 10-Q · filed 2020-03-05 | |||
| 2018-10-31 | -$0.04 10-Q · filed 2019-12-09 | ||||
| 2018-07-31 | -$0.93 10-K · filed 2019-10-04 | ||||
| 2018-04-30 | -$0.04 10-Q · filed 2019-06-05 | -$0.83 10-Q · filed 2019-06-05 | |||
| 2018-01-31 | -$0.04 10-Q · filed 2019-03-12 | -$0.79 10-Q · filed 2019-03-12 | |||
| 2017-10-31 | -$0.74 10-Q · filed 2018-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |